Market Research Logo

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

The Global In Vitro Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest In Vitro Diagnostics agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review In Vitro Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering In Vitro Diagnostics partnering deals.

The report presents financial deal term values for In Vitro Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the In Vitro Diagnostics partnering field; both the leading deal values and most active In Vitro Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 400 online deal records of actual In Vitro Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of In Vitro Diagnostics dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in In Vitro Diagnostics dealmaking since 2010, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading In Vitro Diagnostics deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in In Vitro Diagnostics dealmaking with a brief summary followed by a comprehensive listing of In Vitro Diagnostics deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of In Vitro Diagnostics partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of In Vitro Diagnostics partnering deals signed and announced since Jan 2010. The chapter is organized by specific In Vitro Diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by In Vitro Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in In Vitro Diagnostics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of In Vitro Diagnostics technologies and products.

Key benefits

Global In Vitro Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of In Vitro Diagnostics deal trends since 2010
Access to headline, upfront, milestone and royalty data
Analysis of the structure of In Vitro Diagnostics agreements with numerous real life case studies
Detailed access to actual In Vitro Diagnostics contracts entered into by leading biopharma companies
Identify most active In Vitro Diagnostics dealmakers since 2010
Insight into terms included in a In Vitro Diagnostics partnering agreement, with real world examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global In Vitro Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to In Vitro Diagnostics trends and structure of deals entered into by leading companies worldwide.

In Vitro Diagnostics Partnering Terms and Agreements includes:

Trends in In Vitro Diagnostics dealmaking in the biopharma industry since 2010
Analysis of In Vitro Diagnostics deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life In Vitro Diagnostics deals
Access to In Vitro Diagnostics contract documents
Leading In Vitro Diagnostics deals by value since 2010
Most active In Vitro Diagnostics dealmakers since 2010

In Global In Vitro Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global In Vitro Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 400 In Vitro Diagnostics deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in In Vitro Diagnostics dealmaking
    • Introduction
    • In Vitro Diagnostics partnering over the years
    • Most active In Vitro Diagnostics dealmakers
    • In Vitro Diagnostics partnering by deal type
    • In Vitro Diagnostics partnering by therapy area
    • Deal terms for In Vitro Diagnostics partnering
      • In Vitro Diagnostics partnering headline values
        • Table In Vitro Diagnostics deals with a headline value
      • In Vitro Diagnostics deal upfront payments
        • Table In Vitro Diagnostics deals with an upfront value
      • In Vitro Diagnostics deal milestone payments
        • Table In Vitro Diagnostics deals with a milestone value
      • In Vitro Diagnostics royalty rates
  • Leading In Vitro Diagnostics deals
    • Introduction
    • Top In Vitro Diagnostics deals by value
      • Table Top In Vitro Diagnostics deals by value since 2010
  • Most active In Vitro Diagnostics dealmakers
    • Introduction
    • Most active In Vitro Diagnostics dealmakers
    • Most active In Vitro Diagnostics partnering company profiles
      • Oxford Immunotec
      • Quotient Biodiagnostics
      • Critical Diagnostics
      • Akers Biosciences
      • Illumina
      • National Institutes of Health
      • Quest Diagnostics
      • Radient Pharmaceuticals
      • Abbott Laboratories
      • Sequenom
      • Epigenomics
      • Integrity Applications
      • Life Technologies
      • Roche
      • Roche Diagnostics
      • Siemens Healthcare Diagnostics
      • Thermo Fisher Scientific
      • Becton Dickinson
      • Duke University
      • Exosome Diagnostics
      • Mabtech
      • Qiagen
      • Royal Philips Electronics
      • Rutgers University
      • Siemens Healthcare
  • In Vitro Diagnostics contracts dealmaking directory
    • Introduction
    • In Vitro Diagnostics contracts dealmaking directory
  • In Vitro Diagnostics dealmaking by technology type
    • In vitro diagnostics
  • Partnering resource center
    • Online partnering
    • Partnering events
    • Further reading on dealmaking
  • Appendices
    • In Vitro Diagnostics deals by company A-Z
      • 20/20 GeneSystems
      • 36 Strategies General Trading
      • Abaxis
      • Abbott Laboratories
      • Abcam
      • Abnova
      • AB Analitica
      • Accuscience
      • Achaogen
      • ADT Altona Diagnostic Technologies
      • Advanced Biological Laboratories
      • Advanced Cell Diagnostics
      • Advanced Liquid Logic
      • Advanced Technology Company
      • Aerocrine
      • Aethlon Medical
      • Affymetrix
      • Agena Bioscience
      • AirStrip Technologies
      • Air Force General Hospital
      • AIT Laboratories
      • Akers Biosciences
      • Akonni Biosystems
      • AKSA Medical
      • Alere
      • ALK-Abello
      • Alliance Pharma
      • Almac Diagnostics
      • Alphaeon
      • ALR Technologies
      • Amarantus BioSciences
      • AMDL Diagnostics
      • American Pathology Partners
      • American Red Cross
      • Amgen
      • Amil Participacoes
      • AmpTec
      • Angel Biomedical
      • Aperio Technologies
      • Appistry
      • Appleton Medical Services
      • Applied Spectral Imaging
      • Aradigm
      • Argos Soditic
      • Ariana Pharma
      • Ariosa Diagnostics
      • Arizona State University
      • ARK Diagnostics
      • Arno Therapeutics
      • Arterial Health International
      • ARUP Laboratories
      • AspenBio Pharma
      • Association for Frontotemporal Degeneration
      • Assut
      • AstraZeneca
      • AstraZeneca HealthCare Foundation
      • Asuragen
      • Austrian Institute of Technology
      • AVL Sofia
      • AyoxxA Biosystems
      • Banyan Biomarkers
      • Barbara Davis Center
      • Bayer
      • Baylor College of Medicine
      • Beaujon Hospital
      • Beckman Coulter
      • Becton Dickinson
      • Beddit
      • Beijing Clear Biotech
      • Bill and Melinda Gates Foundation
      • Bio-Asia Diagnostics
      • Bio-Manguinhos
      • Bio-Rad Laboratories
      • Biocare Medical
      • BioChain
      • Biochemmack
      • Biocortech
      • Biodesix
      • BioFire Diagnostics
      • BioFront Technologies
      • Biohit
      • Biomedical Advanced Research and Development Authority
      • BioMed X Innovation Center
      • BioMerieux
      • Biomiga Diagnostics
      • Biomnis
      • Biosearch Technologies
      • BioTelemetry
      • BioVendor
      • Bioventix
      • Biozym Scientific
      • Bird Foundation
      • Blood Centers of America
      • Bonnie J. Addario Lung Cancer Foundation
      • Boston Scientific
      • Boston University
      • Boston University School of Medicine
      • Broad Institute
      • Brown University
      • Bruker
      • Bruker Daltonics
      • Burnet Institute
      • BVT Technologies
      • Cambridge Bioscience
      • Cancer Cytogenomics Microarray Consortium
      • Cancer Genetics
      • Capnia
      • Caputron Medical
      • Cardiac Science
      • CardiNor
      • CardioLogic
      • Cardiorentis
      • Carl Zeiss Meditec
      • Carter BloodCare
      • Cedars-Sinai Medical Center
      • Celgene
      • Cellmid
      • Cell Marque
      • Centers for Disease Control and Prevention
      • Center for Connected Health
      • Center for Human Genetics and Laboratory Medicine
      • Cepheid
      • Chembio Diagnostics
      • Children's Hospital Boston
      • Cilag AG
      • Cisbio Bioassays
      • CliniSciences
      • Clovis Oncology
      • Collagen Solutions Plc
      • CombiMatrix
      • Commonwealth Laboratories
      • Companion Dx Reference Lab
      • Copan Diagnostics
      • Corgenix Medical
      • Coriell Institute for Medical Research
      • Coronado Biosciences
      • Creative Biolabs
      • Creative Diagnostics
      • Critical Diagnostics
      • Cruinn Diagnostics
      • Curetis
      • Cylex
      • Cytovas
      • C R Bard
      • DaAn Gene
      • Dana-Farber Cancer Institute
      • DaRui Biotech
      • DaVita HealthCare Partners
      • Daxor
      • Debiopharm
      • DeCODE Genetics
      • Defense Advanced Research Projects Agency
      • Defense Threat Reduction Agency
      • Dehaier Medical Systems
      • DenMat Holdings
      • Dermpath Diagnostics
      • DermTech
      • DexCom
      • Diagenode
      • DiagnoCure
      • Diagnosticos da America
      • Diagnostic Hybrids
      • DiaSorin
      • DiaSorin Trivitron Healthcare
      • Diasys Diagnostics Systems
      • Diatherix
      • Diatron Messtechnik
      • Diaxonhit
      • DigiPath Solutions
      • Duke Medical
      • Duke University
      • DuPont
      • DxNA
      • DxTerity
      • Dynacare Laboratories
      • EarlySense
      • EchoPixel
      • Eddingpharm
      • Eiken Chemical
      • Eisai
      • EKF Diagnostics
      • EMD Millipore
      • Emergo Group
      • Enterome Bioscience
      • Enzo Clinical Labs
      • Epigenomics
      • Epitomics
      • Epizyme
      • Eppendorf
      • Eurobio
      • Eurofins Genomics
      • European Network for Translational Research in Atrial Fibrillation (EUTRAF)
      • Event Cardio Group
      • ExonHit Therapeutics
      • Exosome Diagnostics
      • Exosome Sciences
      • ExoStat Medical
      • Eyesense
      • FABPulous
      • Facebook
      • Farla
      • Felkasta JSC
      • Flemish agency for Innovation by Science and Technology
      • Fluidigm
      • Fondamental
      • Food and Drug Administration National Center for Toxicological Research
      • Fosun Pharmaceutical
      • Foundation for Innovative New Diagnostics
      • Foundation Medicine
      • Fraunhofer Institute for Microelectronic Circuits and Systems
      • Freie Universität Berlin
      • Fresenius Kabi Pharmaceuticals
      • Fujikura Kasei
      • Future Diagnostics
      • Galapagos
      • Gamma Therapeutics
      • Gaur Diagno
      • Gen-Probe
      • Genalyte
      • GenCell Biosystems
      • Genelabs Technologies
      • Genentech
      • Generex Biotechnology
      • Genetic Technologies
      • GenMark Diagnostics
      • Genoma
      • Gentag
      • GenTegra
      • George Mason University
      • German Cancer Research Center
      • GE Healthcare
      • Global Discovery Biosciences
      • GlySens
      • GNS Healthcare
      • Good Start Genetics
      • Grifols
      • Guangzhou Pharmaceutical Group
      • Guided Therapeutics
      • GuoMinXinHe Investment Fund
      • Halozyme Therapeutics
      • Hamner Institutes for Health Sciences
      • HeadSense Medical
      • Health-Chem Diagnostics
      • Healthcare 21
      • Healthsense
      • HemoCue
      • Henry M. Jackson Foundation
      • Hepregen
      • HiberGene Diagnostics
      • HighRes Biosolutions
      • Hologic
      • Hong Kong Polytechnic University
      • Horizon 2020
      • Horizon Discovery
      • HTG Molecular Diagnostics
      • Hyglos
      • IBA
      • Icahn School of Medicine at Mount Sinai
      • Idera Pharmaceuticals
      • Illumina
      • IMDEA Food
      • IMI
      • Immuno Diagnostic
      • IncellDx
      • InDi Molecular
      • InGen BioSciences
      • Innova Biosciences
      • Inova Translational Medicine Institute
      • Inserm
      • Insight Genetics
      • Institute for Commercialization of Public Research
      • Institute for Global Food Security
      • Institute for Translational Oncology Research
      • Institute of Medical Microbiology
      • Institute of Molecular Biology of Paraná (IBMP)
      • Institut De Recherche Pour Le Developpement (IRD)
      • Institut Gustave Roussy
      • Institut National Recherche Agronomique
      • Insulet
      • Integrated Diagnostics
      • Integrated DNA Technologies
      • Integrated Sciences
      • Integrity Applications
      • Intelligent Medical Devices
      • Intramedic
      • Intrinsic LifeSciences
      • Invetech
      • Iowa State University
      • IPMD
      • IQ Products
      • IRhythm Technology
      • ISIS Innovation
      • Itamar Medical
      • IVD Bulgaria
      • Janssen Pharmaceuticals
      • Janssen Pharmaceutica NV
      • Johns Hopkins University
      • Kinetic Concepts
      • Kirkegaard and Perry Laboratories
      • Knome
      • Konica Minolta
      • Lab21
      • Labco
      • Labmedicin Skane
      • Laboratoire Cerba
      • Laboratorios LETI
      • Laboratory Corporation of America
      • Laboratory Supply Company (LABSCO)
      • Laboratory Viollier
      • LabPro
      • LabStyle Innovations
      • LamdaGen
      • Launch Diagnostics
      • LDR Holding
      • LED Medical Diagnostics
      • Lee's Pharmaceutical
      • Leica Biosystems
      • Leica Microsystems
      • Leidos Holdings
      • Leukocare
      • LifeCaring Technologies
      • LifeWatch Services
      • Life Biomedical
      • Life Technologies
      • Life Technologies Corporation
      • Life Technologies DaAn Diagnostics
      • Lineagen
      • LipoScience
      • Lonza
      • Luminex
      • Lutheran Medical Center
      • Lyra Health
      • Mabtech
      • MagBioSense
      • MagneMotion
      • Makerere University
      • Maritim
      • MaRS Innovation
      • Massachusetts General Hospital
      • Massachusetts Institute of Technology
      • Masterlab
      • Matrix-Bio
      • Mayo Clinic
      • Mayo Medical Laboratories
      • MBio Diagnostics
      • MDxHealth
      • Medical College of Wisconsin
      • Medicon Hellas
      • Medicyte
      • Medidata Solutions
      • Medimass
      • Medivo
      • MedMira
      • Medtronic
      • Mellitus
      • Memorial Sloan Kettering Cancer Center
      • Memory Dx
      • Menarini
      • MentisCura
      • Merck and Co
      • Metabolon
      • MGC Diagnostics
      • MicroCoat Biotechnologie
      • MikroLink
      • Ministry of Health (Brazil)
      • Miraca Life Sciences
      • Mitobridge
      • Mitsui
      • Modernizing Medicine
      • MolecularMD
      • Molecular Detection
      • Mologic
      • Morgridge Institute for Research
      • Mortara Instruments
      • MOR Institute for Medical Data
      • MRC Technology
      • N-of-One
      • Nanobeak
      • NanoSpeed Diagnostics
      • NanoString Technologies
      • NASA
      • Natera
      • National Cancer Institute
      • National Center for Advancing Translational Sciences (NCATS)
      • National Center for Foreign Animal and Zoonotic Disease Defense
      • National Heart, Lung and Blood Institute
      • National Institutes of Health
      • National Institute for Environmental Health Sciences
      • National Institute of Allergy and Infectious Diseases
      • National Institute of Child Health and Human Development
      • National Institute of Diabetes and Digestive and Kidney Diseases
      • National Institute of Neurological Disorders and Stroke
      • National Institute on Aging
      • Naval Medical Logistics Command
      • Neurosoft
      • Neurovirtual
      • Neuro Kinetics
      • NewBridge Pharmaceuticals
      • New England Biolabs
      • New Oncology
      • New York University
      • NextCODE Health
      • NextGxDx
      • Nicox
      • Nipro Corporation
      • Nipro Diagnostics
      • NMI Natural and Medical Sciences Institute
      • Nordic Biolabs
      • Nordic Diagnostica
      • North Carolina Biotechnology Center
      • North Carolina State University
      • North Georgia Healthcare
      • NovaMedica
      • Novartis
      • Novartis Vaccines and Diagnostics
      • Noviosense
      • Nuclea Biotechnologies
      • Oasis Diagnostics
      • Office of the Chief Scientist
      • Oncgnostics
      • Ontario Institute for Cancer Research
      • OPKO Health
      • Optimed
      • OraSure Technologies
      • Oregon Health Sciences University
      • Orion Bionetworks
      • Orion Diagnostica Oy
      • Ortho-Clinical Diagnostics
      • Oswaldo Cruz Foundation (Fiocruz)
      • OvaMed
      • Oxford Gene Technology
      • Oxford Immunotec
      • Oxford Nanopore Technologies
      • Pacific Biosciences
      • Pacific BioScience of California
      • PathoGene
      • PathoGenetiX
      • Pathogenica
      • Pathway Diagnostics
      • Pathwork Diagnostics
      • Perceptive Imagineering
      • PerkinElmer
      • Pfizer
      • PharmLogic
      • Pharmsynthez
      • Physician's Choice Laboratory Services
      • Polymedco
      • Polymer Technology Systems
      • PositiveID
      • Premier Purchasing Partners
      • Pressure BioSciences
      • PreventionGenetics
      • Primeradx
      • Probe Scientific
      • Procaps
      • ProNova
      • ProPath
      • Prostate Cancer Foundation (PCF)
      • Protagen
      • Qiagen
      • Quanterix
      • QuantumDx
      • Quest Diagnostics
      • Quidel
      • Quotient Biodiagnostics
      • Quotient Bioscience
      • Radboud University Nijmegen Medical Centre
      • Radient Pharmaceuticals
      • Raiing Medical
      • Rainbow BioSciences
      • Rancho BioSciences
      • Randox Laboratories
      • RayBiotech
      • Redcoat Solutions
      • Regenstrief Institute
      • Renishaw Diagnostics
      • Respiratory Motion
      • Response Biomedical
      • Restech
      • Ridge Diagnostics
      • Riken Genesis
      • Roche
      • Roche Diagnostics
      • Romer Labs
      • Royal Philips Electronics
      • Rubicon Genomics
      • Rutgers University
      • Sagentia
      • Saladax Biomedical
      • Salk Institute
      • Samsung Electronics
      • Schnitzler Cardiovascular Consultants
      • Schott
      • Scienion
      • SDIX
      • Seegene
      • Senseonics
      • Sensocure
      • Sentio
      • Sequenom
      • Sequenta
      • Seracare Life Sciences
      • Shanghai Elite Biotech
      • Shanghai Fosun Long March Medical Science
      • Shanghai Industrial ìTechnology Research Institute (SITRI)
      • Shanghai Nanodigmnio Biotechnology
      • Shuwen Biotech
      • Siemens Healthcare
      • Siemens Healthcare Diagnostics
      • Singapore Eye Research Institute (SERI)
      • Singulex
      • SmartGene
      • Sony DADC
      • Sopachem
      • Sorrento Therapeutics
      • Spartan Bioscience
      • Spinomix
      • Spot on Sciences
      • SQI Diagnostics
      • SRI International
      • Stanford University
      • Statens Serum Institute
      • Stemcell Technologies
      • Stratatech
      • STRATEC Biomedical Systems AG
      • Sunnybrook Health Sciences Centre
      • Sunrise Medical Laboratories
      • Susan G. Komen for the Cure
      • Swift Biosciences
      • SYGNIS Pharma
      • SynapDx
      • Synthetic Biologics
      • Systagenix Wound Management
      • T2 Biosystems
      • Taconic
      • Talecris Biotherapeutics
      • Tandem Diabetes Care
      • Target Discovery
      • TB Alliance
      • Tecan
      • Technogenetics
      • Technology Strategy Board (UK)
      • Telenatal
      • Teva Pharmaceutical Industries
      • Texas AgriLife Research
      • Theorem Clinical Research
      • Thermo Fisher Scientific
      • The Biodesign Institute
      • The Doctors Laboratory
      • Three Rivers Provider Network
      • Threshold Pharmaceuticals
      • Tocagen
      • Tokra Medikal
      • Transgenomic
      • Trillium Diagnostics
      • Trivitron Healthcare
      • True North Laboratory
      • TTP Group
      • Tulane University
      • Tute Genomics
      • Ultramedix Australasia
      • Unilab
      • United Nations Children Fund
      • United States Agency for International Development
      • Universal Biosensors
      • University College Dublin
      • University Hospital Heidelberg
      • University of Arkansas
      • University of Bradford
      • University of California Berkeley
      • University of California Santa Barbara
      • University of Cambridge
      • University of Hong Kong
      • University of Illinois
      • University of Medicine and Dentistry of New Jersey (UMDNJ)
      • University of Minnesota
      • University of Oxford
      • University of Pennsylvania
      • University of Rhode Island
      • University of Southampton
      • University of Washington
      • University of Wisconsin-Madison
      • University Pierre Marie Curie
      • US Army Medical Research Institute of Infectious Diseases
      • Valeant Pharmaceuticals
      • Vantage Health
      • Vela Diagnostics
      • Ventana Medical Systems
      • Venter Pharma
      • Verax Biomedical
      • Veridex
      • Verinata Health
      • ViiV Healthcare
      • ViraCor Laboratories
      • Viral Hemorrhagic Fever Consortium
      • Visiometrics
      • Vital Connect
      • ViveBio
      • Vivione Biosciences
      • Vivonoetics
      • VWR International
      • Walter Reed Army Institute of Research
      • WanJiaYuan International Geriatric Hospital
      • Waters Corporation
      • Wellbridge Health
      • Womack Army Medical Center
      • Wuhan Kindstar Diagnostics
      • XCellCure
      • Xention
      • YBUX
      • Zeus Scientific
      • Zoetis
      • ZSpace
    • In Vitro Diagnostics deals by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • In Vitro Diagnostics deals by deal type
      • Asset purchase
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Co-promotion
      • CRADA
      • Development
      • Distribution
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Manufacturing
      • Manufacturing - OEM
      • Marketing
      • Option
      • Promotion
      • Research
      • Settlement
      • Spin out
      • Sub-license
      • Supply
      • Technology transfer
      • Termination
    • In Vitro Diagnostics deals by therapy area
      • Breast
      • Cardiovascular
      • Atrial fibrillation
      • Congestive heart failure
      • Coronary artery disease
      • Hypercholesterolemia
      • Hypertension
      • Ischemic heart disease
      • Myocardial Infarction
      • Peripheral arterial disease
      • Central Nervous System
      • Meningitis
      • Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig's Disease)
      • Multiple sclerosis
      • Parkinson's disease
      • Spinal cord
      • Stroke
      • Traumatic Brain Injury
      • Dental
      • Mucositis
      • Dermatology
      • Dermatitis
      • Wound healing
      • Gastrointestinal
      • Esophageal reflux
      • Gastritis
      • Gastroenteritis
      • Inflammatory bowel disease
      • Irritable bowel syndrome
      • Genetic disorders
      • Down syndrome
      • Huntington's disease
      • Rare genetic disorders
      • Sickle cell disease
      • Chronic kidney disease (CKD)
      • Stage 3
      • Stage 4
      • Renal failure
      • Gynaecology
      • Human papillomavirus (HPV)
      • Hematology
      • Anemia
      • Hemophilia
      • Thrombocytopenia
      • Hospital care
      • Transplantation
      • Immunology
      • AIDS
      • Allergy
      • Other autoimmune
      • Inflammation
      • Infectives
      • Bacterial
      • Anthrax
      • Clostridium difficile
      • Escherichia Coli (E-coli)
      • Helicobacter Pylori
      • Lyme disease
      • Methicillin-resistant Staphylococcus aureus (MRSA)
      • Pseudomonas aeruginosa
      • Salmonella
      • Sepsis
      • Tuberculosis (TB)
      • Fungal
      • Parasitic
      • African trypanosomiasis (Sleeping sickness)
      • Dengue fever
      • Malaria
      • Viral
      • Cytomegalovirus
      • Ebola
      • Herpes simplex
      • HIV
      • Influenza
      • Metabolic
      • Cirrhosis
      • Diabetes
      • Type 1
      • Type 2
      • Hyperthyroidism
      • Liver disease
      • Nutrition and vitamins
      • Rheumatoid arthritis
      • Obstetrics
      • Fetal abnormalities
      • Pregnancy
      • Miscarriage
      • Prenatal screening
      • Preterm labour
      • Oncology
      • Brain cancer
      • Breast cancer
      • Cervical cancer
      • Colorectal cancer
      • Esophageal cancer
      • Acute lymphoblastic leukemia
      • Acute myelogenous leukemia
      • Chronic myelogenous leukemia
      • Liver cancer
      • Lung cancer
      • Non small cell lung cancer
      • Lymphoma
      • Non Hodgkin's lymphoma
      • Melanoma
      • Metastases
      • Ovarian cancer
      • Pancreatic cancer
      • Prostate cancer
      • Solid tumors
      • Thyroid cancer
      • Ophthalmics
      • Age-related macular degeneration
      • Cataracts
      • Pediatrics
      • Psychiatry
      • Anxiety disorder
      • Dementia
      • Alzheimers
      • Depression
      • Autism
      • Sleep disorders
      • Sleep apnoea
      • Drugs
      • Obesity
      • Respiratory
      • Asthma
      • Chronic obstructive pulmonary disease
      • Sensory organs
      • Sexually transmitted disease (STI)
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from Current Partnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report